Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FB742
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,625
Award facts
- Contract value 100% obligated
- $20,624.72 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $20,624.72 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 7, 2025, with an ultimate completion date of the same day. This firm fixed price delivery order, issued without set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement extending through December 2026. The work is being performed at the company's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support federal medical procurement needs, including medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains.
This delivery order exemplifies AmerisourceBergen's role as a critical vendor within DLA's pharmaceutical supply chain, supporting military healthcare systems and other government agencies including the Defense Health Agency and U.S. Coast Guard. The company's federal contracting history demonstrates consistent success in competing for open awards across multiple therapeutic categories, from diabetes medications to neurological treatments and pain management pharmaceuticals. The competitively awarded delivery order structure allows DLA to leverage the broader indefinite delivery vehicle while maintaining flexibility in ordering specific pharmaceutical products and supplies as operational needs arise throughout the federal government's healthcare systems.
Quick answers
Who was awarded contract SPE2DU26FB742?
SPE2DU26FB742 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DU26FB742 worth?
The government has obligated $20,625 on SPE2DU26FB742.
Is contract SPE2DU26FB742 an order under another contract?
Yes. SPE2DU26FB742 is a delivery order under SPE2DU25D4211, an indefinite delivery contract.
Was contract SPE2DU26FB742 competed?
The extent of competition for SPE2DU26FB742 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award